WuXi AppTec Co., Ltd. Class H (HK:2359)
:2359
Want to see HK:2359 full AI Analyst Report?
Comparison Results
WuXi AppTec Co., Ltd. Class H
HK$122.90
HK$351.41B
16.25
99.08%
8 Buy
0 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$35.72
HK$137.23B
24.33
37.23%
11 Buy
1 Hold
0 Sell
Strong Buy
Hangzhou Tigermed Consulting Co., Ltd. Class H
HK$54.00
HK$38.69B
151.86
23.82%
7 Buy
0 Hold
0 Sell
Strong Buy
Pharmaron Beijing Co., Ltd. Class H
HK$24.14
HK$51.05B
22.45
36.62%
7 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$39.76
HK$203.76B
34.88
35.21%
10 Buy
0 Hold
0 Sell
Strong Buy
WuXi XDC Cayman, Inc.
HK$54.80
HK$72.74B
48.72
49.48%
9 Buy
0 Hold
0 Sell
Strong Buy
Performance Comparison
HK:2359
WuXi AppTec Co., Ltd. Class H
129.30
64.53
99.62%
HK:2269
Wuxi Biologics (Cayman)
33.14
8.44
34.17%
HK:3347
Hangzhou Tigermed Consulting Co., Ltd. Class H
33.06
6.03
22.30%
HK:3759
Pharmaron Beijing Co., Ltd. Class H
18.28
4.86
36.19%
HK:3692
Hansoh Pharmaceutical Group Company Limited
33.60
8.58
34.29%
HK:2268
WuXi XDC Cayman, Inc.
57.70
19.35
50.46%